174 related articles for article (PubMed ID: 18438327)
1. Statement 3: a low serum IGF-I Level in idiopathic short stature patients indicates partial GH insensitivity.
Bang P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():841-6. PubMed ID: 18438327
[No Abstract] [Full Text] [Related]
2. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
Backeljauw P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
[No Abstract] [Full Text] [Related]
3. Statement 1: a serum insulin-like growth factor I (IGF-I) level should be part of the evaluation of children with short stature.
Cohen P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():834-6. PubMed ID: 18438325
[No Abstract] [Full Text] [Related]
4. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
Park P; Cohen P
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
[TBL] [Abstract][Full Text] [Related]
6. Partial growth hormone insensitivity.
Johnston LB; Savage MO
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():251-7. PubMed ID: 10698589
[TBL] [Abstract][Full Text] [Related]
7. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
[No Abstract] [Full Text] [Related]
8. High growth hormone levels in clinically short stature children.
Awan TM; Sattar A; Khattak IG
J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of disorders of IGF-I synthesis and action.
Wit JM
Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():538-40. PubMed ID: 22423513
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of endocrine disease: limitations of the IGF1 generation test in children with short stature.
Coutant R; Dörr HG; Gleeson H; Argente J
Eur J Endocrinol; 2012 Mar; 166(3):351-7. PubMed ID: 22048966
[TBL] [Abstract][Full Text] [Related]
11. IGFs and IGFBPs in GH insensitivity.
Savage MO; Blair JC; Jorge AJ; Street ME; Ranke MB; Camacho-Hübner C
Endocr Dev; 2005; 9():100-106. PubMed ID: 15879692
[TBL] [Abstract][Full Text] [Related]
12. Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.
Laron Z
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():188-91. PubMed ID: 16641857
[TBL] [Abstract][Full Text] [Related]
13. Phenotypes, investigation and treatment of primary IGF-1 deficiency.
Savage MO
Endocr Dev; 2013; 24():138-49. PubMed ID: 23392102
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
15. Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
Hardin DS
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():857-60. PubMed ID: 18438330
[No Abstract] [Full Text] [Related]
16. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone insensitivity: diagnostic and therapeutic approaches.
Kurtoğlu S; Hatipoglu N
J Endocrinol Invest; 2016 Jan; 39(1):19-28. PubMed ID: 26062520
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
20. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I).
Breil T; Kneppo C; Bettendorf M; ; Müller HL; Kapelari K; Schnabel D; Woelfle J
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):895-902. PubMed ID: 29995632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
